Display options
Cite
Baldi A, Santini D, De Luca A, et al. cDNA array technology in melanoma: an overview. J Cell Physiol. 2003;196(2):219-23doi: 10.1002/jcp.10255.
Baldi, A., Santini, D., De Luca, A., & Paggi, M. G. (2003). cDNA array technology in melanoma: an overview. Journal of cellular physiology, 196(2), 219-23. https://doi.org/10.1002/jcp.10255
Baldi, Alfonso, et al. "cDNA array technology in melanoma: an overview." Journal of cellular physiology vol. 196,2 (2003): 219-23. doi: https://doi.org/10.1002/jcp.10255
Baldi A, Santini D, De Luca A, Paggi MG. cDNA array technology in melanoma: an overview. J Cell Physiol. 2003 Aug;196(2):219-23. doi: 10.1002/jcp.10255. PMID: 12811814.
Copy Download .nbib Format: NLM
Share it on

J Cell Physiol. 2003 Aug;196(2):219-23. doi: 10.1002/jcp.10255.

cDNA array technology in melanoma: an overview.

Journal of cellular physiology

Alfonso Baldi, Daniele Santini, Antonio De Luca, Marco G Paggi

Affiliations

  1. Regina Elena Cancer Institute, CRS, Via delle Messi d'Oro, Rome, Italy.

PMID: 12811814 DOI: 10.1002/jcp.10255

Abstract

Genetic aberrations, mostly resulting in changes in gene expression, are critical events in cancer onset and progression. The advent of the cDNA array technology allows the screening and the efficient measurement of expression of thousands genes simultaneously in a wide spectrum of experimental and clinical models. This genomic scale approach is being currently used to obtain global views of human cancer gene expression and to identify genetic markers that might be important for diagnosis, prognosis, and therapy. This review discusses some recent findings obtained by means of cDNA arrays investigating the human melanoma.

Copyright 2003 Wiley-Liss, Inc.

MeSH terms

Publication Types